Global Pregnancy and Ovulation Testing Market Growth (Status and Outlook) 2024-2030
A pregnancy test attempts to determine whether or not a woman is pregnant. Indicative markers are found in blood and urine, and pregnancy tests require sampling one of these substances. The first of these markers to be discovered, human chorionic gonadotropin (hCG), was discovered in 1930 to be produced by the syncytiotrophoblast cells of the fertilised ova (eggs).
The global Pregnancy and Ovulation Testing market size is projected to grow from US$ 215380 million in 2023 to US$ 276460 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Pregnancy and Ovulation Testing Industry Forecast” looks at past sales and reviews total world Pregnancy and Ovulation Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Pregnancy and Ovulation Testing sales for 2024 through 2030. With Pregnancy and Ovulation Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pregnancy and Ovulation Testing industry.
This Insight Report provides a comprehensive analysis of the global Pregnancy and Ovulation Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pregnancy and Ovulation Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pregnancy and Ovulation Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pregnancy and Ovulation Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pregnancy and Ovulation Testing.
The increasing acceptance of home testing kits to check the possibility of pregnancy is projected to spur market demand during the forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Pregnancy and Ovulation Testing market by product type, application, key players and key regions and countries.
Segmentation by type
Pregnancy Testing
Ovulation Testing
Segmentation by application
Fertility Centers
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SPD
Church & Dwight
BioMerieux
Abbott
Rohto
Mankind Pharma
Geratherm Medical
Fairhaven Health
Quidel Corporation
Wondfo
Arax
Egens Biotech
RunBio
CIGA Healthcare
Please note: The report will take approximately 2 business days to prepare and deliver.